, Tracking Stock Market Picks
Enter Symbol:
Endologix Inc (ELGX) [hlAlert]

up 274.56 %

Endologix Inc (ELGX) rated Buy with price target $6 by Lazard Capital Mkts

Posted on: Thursday,  Jul 2, 2009  9:37 AM ET by Lazard Capital Mkts

Lazard Capital Mkts rated Buy Endologix Inc (NASDAQ: ELGX) on 07/02/2009, when the stock price was $3.46.
Since then, Endologix Inc has gained 274.57% as of 01/14/2016's recent price of $12.96.
If you would have followed this Lazard Capital Mkts's recommendation on ELGX, you would have gained 274.56% of your investment in 2387 days.

Endologix, Inc., incorporated in March 1992, develops, manufactures, markets and sells treatments for aortic disorders. The Company?s product, the Powerlink System is a minimally invasive device for the treatment of abdominal aortic aneurysm (AAA). AAA is a weakening of the wall of the aorta, an artery of the body. Once AAA develops, it continues to enlarge and if left untreated becomes susceptible to rupture. The Powerlink System is a catheter and endoluminal stent graft (ELG) system. The device consists of a self-expanding cobalt chromium alloy stent cage covered by expanded polytetrafluoroethylene (ePTFE), a surgical graft material. Sale of its Powerlink System in the United States, Europe, Japan and Latin America are the primary sources of the Company?s revenues.

Lazard Capital Markets’ research team is broadly recognized for its insight, thoroughness, and objectivity. Lazard Capital Markets’ goal is to help our clients make the best-informed decisions by providing timely, thoughtful analysis as well as access to company management teams and industry thought leaders. Lazard Capital Markets’ industry-focused analysts strive to identify emerging sector trends as well as bottom-up fundamental issues affecting their stocks under coverage. We add value by conducting extensive primary survey work, hosting proprietary events, cultivating industry contacts, and participating in relevant industry conferences.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/2/2009 9:37 AM Buy
3.46 6.00
as of 12/31/2009
1 Week up  13.61 %
1 Month up  41.74 %
3 Months down  -2.90 %
1 YTD up  73.69 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy